Epizyme, Inc. is a clinical-stage biopharmaceutical company. The Company discovers, develops, and plans to commercialize epigenetic therapies for cancer patients.

Biotechnology

Epizyme

Epizyme's headquarters in Cambridge, MA, United States

Grant Bogle

Shefali Agarwal

John Weidenbruch

Tanja Weber

Victoria Richon

Pablo Legorreta

David M. Mott

Michael F. Giordano

Carl Goldfischer

Ken Bate

Roy A. Beveridge

Carol Stuckley

Kevin T. Conroy

The Board Governance team at Epizyme is responsible for providing strategic oversight and guidance to the company's leadership. This team ensures compliance with legal and regulatory standards, facilitates effective communication among board members, and helps shape the long-term vision and governance policies of the organization, ultimately supporting its mission to develop innovative epigenetic therapies for cancer patients.

Board Governance

The Leadership Team at Epizyme plays a pivotal role in steering the company’s strategic direction and operational execution. Comprised of executives from diverse specialties, including scientific research, clinical development, and commercial strategy, the team collaborates to drive the discovery and development of innovative epigenetic therapies for cancer. They also oversee portfolio management, ensure quality in technical operations, and facilitate partnerships that support the company’s mission to improve outcomes for cancer patients.

Leadership Team

��

Epizyme

Org chart

Board & advisors

Teams

Board Governance

Leadership Team

Offices

��������

Epizyme

Org chart

Board & advisors

Teams

Board Governance

Leadership Team

Offices

Related companies

��